Free Trial

Cross Country Healthcare (NASDAQ:CCRN) Posts Earnings Results, Misses Expectations By $0.07 EPS

Cross Country Healthcare logo with Business Services background
Remove Ads

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) issued its quarterly earnings results on Wednesday. The business services provider reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by ($0.07), Zacks reports. The company had revenue of $309.94 million during the quarter, compared to the consensus estimate of $306.17 million. Cross Country Healthcare had a negative net margin of 0.12% and a positive return on equity of 5.38%.

Cross Country Healthcare Trading Up 0.8 %

Shares of CCRN stock traded up $0.13 during trading hours on Friday, hitting $15.93. 481,897 shares of the company were exchanged, compared to its average volume of 526,607. The company has a market capitalization of $522.76 million, a PE ratio of -318.54, a PEG ratio of 3.32 and a beta of 0.44. Cross Country Healthcare has a 52 week low of $9.58 and a 52 week high of $19.25. The business has a 50 day moving average of $17.92 and a two-hundred day moving average of $15.14.

Analyst Ratings Changes

A number of research firms have commented on CCRN. William Blair lowered shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th. JMP Securities reissued a "market perform" rating on shares of Cross Country Healthcare in a research note on Thursday, February 6th. Benchmark downgraded shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 4th. Barrington Research reissued a "market perform" rating on shares of Cross Country Healthcare in a research report on Tuesday, December 10th. Finally, Truist Financial lifted their target price on Cross Country Healthcare from $15.00 to $18.61 and gave the stock a "hold" rating in a report on Thursday, December 5th. Six investment analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $18.54.

Remove Ads

Get Our Latest Report on CCRN

Cross Country Healthcare Company Profile

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Further Reading

Earnings History for Cross Country Healthcare (NASDAQ:CCRN)

Should You Invest $1,000 in Cross Country Healthcare Right Now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 AI Stocks to Watch After NVIDIA’s Dip

3 AI Stocks to Watch After NVIDIA’s Dip

NVIDIA may be down, but the AI boom isn’t slowing anytime soon! While investors react to short-term price swings, smart money is looking at three stocks that could benefit from NVIDIA’s continued domi

Related Videos

7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads